TYRP1 and neoplasm: Therefore, these data indicate that gp75 is targeted by CART-gp75 cells, but not by the 2′3′-cGAMP treatment, providing a scenario in which the immune effects of CART cells and STING-L on tumor cells can be differentially studied.